BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1711191)

  • 1. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
    Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
    Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A; Millington M; Sun LQ; Symonds G
    Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
    Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
    Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the role of CSF-1 independence in myc retrovirus induced monocyte tumorigenesis.
    Eccles MR; Baumbach WR; Cole MD
    Oncogene; 1990 Oct; 5(10):1535-9. PubMed ID: 2250911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
    Blasi E; Radzioch D; Merletti L; Varesio L
    Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1.
    Dolnikov A; Ward RL; Hawkins NJ; Symonds G
    Oncogene; 1996 Mar; 12(6):1189-98. PubMed ID: 8649820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral v-myc infection of primary fetal liver cells: transformation of monocytes in vitro.
    Birchenall-Roberts MC; Engelmann GL; Keller JR; Lohrey N; Ruscetti FW
    Oncogene; 1989 Jun; 4(6):731-5. PubMed ID: 2786619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of murine fibroblasts by a retrovirus encoding the murine c-fms proto-oncogene.
    Rohrschneider LR; Rothwell VM; Nicola NA
    Oncogene; 1989 Aug; 4(8):1015-22. PubMed ID: 2548144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the M-CSF gene in mouse macrophages immortalized by retroviruses carrying a v-myc oncogene.
    Righi M; Sassano M; Valsasnini P; Shammah S; Ricciardi-Castagnoli P
    Oncogene; 1991 Jan; 6(1):103-11. PubMed ID: 1825138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony stimulating factor-1 induced growth stimulation of v-fms transformed fibroblasts.
    Lyman SD; Park L; Rohrschneider LR
    Oncogene; 1988 Oct; 3(4):391-5. PubMed ID: 2856249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
    Wang Y; Iliakis G
    Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of exogenous myc in myelomonocytic cells: acquisition of a more transformed phenotype and inhibition of differentiation induction.
    Chisholm O; Stapleton P; Symonds G
    Oncogene; 1992 Sep; 7(9):1827-36. PubMed ID: 1501891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.
    Zerlin M; Julius MA; Cerni C; Marcu KB
    Oncogene; 1987 Mar; 1(1):19-27. PubMed ID: 3325875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The v-myc oncogene.
    Lee CM; Reddy EP
    Oncogene; 1999 May; 18(19):2997-3003. PubMed ID: 10378695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fms gene and the CSF-1 receptor.
    Sherr CJ; Rettenmier CW
    Cancer Surv; 1986; 5(2):221-32. PubMed ID: 3022923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of macrophage colony-stimulating factor (CSF-1) and its receptor, c-fms, in normal ovarian granulosa cells leads to cell proliferation and tumorigenesis.
    Keshava N; Gubba S; Tekmal RR
    J Soc Gynecol Investig; 1999; 6(1):41-9. PubMed ID: 10065425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
    Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
    Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.